NEOGENOMICS INC's ticker is NEO and the CUSIP is 64049M209. A total of 143 filers reported holding NEOGENOMICS INC in Q4 2016. The put-call ratio across all filers is 0.26 and the average weighting 0.8%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2017 | $71,000 | -7.8% | 9,000 | 0.0% | 0.06% | -11.3% |
| Q4 2016 | $77,000 | +4.1% | 9,000 | 0.0% | 0.06% | +5.1% |
| Q3 2016 | $74,000 | +2.8% | 9,000 | 0.0% | 0.06% | 0.0% |
| Q2 2016 | $72,000 | +18.0% | 9,000 | 0.0% | 0.06% | +11.3% |
| Q1 2016 | $61,000 | -14.1% | 9,000 | 0.0% | 0.05% | -15.9% |
| Q4 2015 | $71,000 | +36.5% | 9,000 | 0.0% | 0.06% | +28.6% |
| Q3 2015 | $52,000 | +6.1% | 9,000 | 0.0% | 0.05% | +19.5% |
| Q2 2015 | $49,000 | +16.7% | 9,000 | 0.0% | 0.04% | +13.9% |
| Q1 2015 | $42,000 | +10.5% | 9,000 | 0.0% | 0.04% | +9.1% |
| Q4 2014 | $38,000 | – | 9,000 | – | 0.03% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Kopp Family Office, LLC | 2,023,355 | $91,395,000 | 37.83% |
| Blue Water Life Science Advisors, LP | 702,222 | $31,719,000 | 11.94% |
| Burrage Capital Management LLC | 147,921 | $6,682,000 | 6.70% |
| PERKINS CAPITAL MANAGEMENT INC | 158,300 | $7,150,000 | 4.06% |
| First Light Asset Management, LLC | 1,148,945 | $51,898,000 | 3.11% |
| Soleus Capital Management, L.P. | 352,007 | $15,900,000 | 2.44% |
| Ranger Investment Management | 832,286 | $37,594,000 | 1.96% |
| Avidity Partners Management LP | 1,367,000 | $61,747,000 | 1.67% |
| Bullseye Asset Management LLC | 108,672 | $4,909,000 | 1.65% |
| Tygh Capital Management, Inc. | 255,541 | $11,543,000 | 1.57% |